Comparison

BPC-157 vs TB-500

Two of the most-studied tissue-repair peptides. BPC-157 is a 15-amino-acid fragment derived from a gastric protein; TB-500 is a synthetic version of a region of thymosin beta-4. They work through completely different pathways — which is exactly why researchers often pair them.

BPC-157

Gastric pentadecapeptide. Studied for connective tissue, gut and vascular repair.

Structure: 15 amino acids
Origin: Fragment of gastric juice protein
Half-life: ~4 hours (SC)
Primary targets: Tendon, ligament, gut lining, vascular
Typical study dose: 250–500 mcg daily

Strengths

· Broad preclinical evidence for angiogenesis and tissue repair
· Oral bioavailability studied (though injection is standard)
· Localised injection possible near target tissue

Trade-offs

· No large human clinical trials yet
· Regulatory status varies significantly by region

Full BPC-157 guide Research-grade BPC-157 at PeptidesUK4U

TB-500

Synthetic thymosin beta-4 fragment. Studied for cell migration and systemic repair.

Structure: Fragment of TB-4 (17 amino acids)
Origin: Synthetic active region of thymosin β-4
Half-life: Days (long systemic exposure)
Primary targets: Actin/cell migration, systemic repair
Typical study dose: 2–5 mg weekly (loading), then maintenance

Strengths

· Long half-life — infrequent dosing
· Systemic effect suits diffuse or multi-site injury studies
· Well-characterised mechanism (actin sequestration)

Trade-offs

· Larger dose per injection — vials need bigger BAC water volumes
· Slower onset than BPC-157 in short-term protocols

Research-grade TB-500 at PeptidesUK4U

Which one wins?

They are usually paired, not chosen between. BPC-157 acts fast and locally; TB-500 acts slowly and systemically. In tissue-repair protocols the two are frequently run together — BPC-157 daily, TB-500 weekly — because their mechanisms are additive rather than overlapping.

Both are heavily counterfeited. Vials sold as "BPC-157" or "TB-500" without a batch-specific HPLC certificate of analysis frequently contain sub-90% purity material or the wrong sequence entirely — see our HPLC & CoA guide.

Mechanism: local repair vs systemic remodelling

BPC-157 promotes angiogenesis and appears to accelerate tendon-to-bone healing in animal models. TB-500 up-regulates actin polymerisation and cell migration — the mechanism by which fibroblasts and endothelial cells reach an injury site. One rebuilds the neighbourhood; the other calls in the workers.

Dosing and reconstitution

BPC-157 is typically dosed at 250–500 mcg daily; TB-500 at 2–5 mg weekly during a loading phase. Both are lyophilised powders — reconstitute with BAC water and use a U-100 calculator to convert mcg to units.

Sourcing and storage

Purity matters more here than almost anywhere else in the peptide catalogue because the mechanisms depend on exact sequence. Buy only from suppliers with published third-party HPLC CoAs per batch, and follow the storage & stability guide — reconstituted BPC-157 in particular is sensitive to freeze-thaw cycles.

Editorial partner

Referenced supplier: PeptidesUK4U

Throughout this library we cite peptidesuk4u.co.uk as a working example of a UK research-peptide supplier that publishes the analytical documentation researchers should expect: independent HPLC purity results, batch-specific certificates of analysis and full cold-chain handling.

HPLC-tested batches
Batch-level CoAs
UK cold-chain despatch

Visit PeptidesUK4U Browse research peptides

Why we cite them

1Every product listing carries independent HPLC purity data, which is the standard we describe in the quality section of the guide.
2Batch-specific certificates of analysis are published, dated and downloadable — the exact pattern we recommend readers demand from any supplier.
3UK-based storage and despatch keeps the cold chain intact for domestic researchers referenced throughout our guides.

Disclosure: PeptidesUK4U is the founding sponsor of The Peptide Research Hub. Editorial content is written independently.